Your browser doesn't support javascript.
loading
Long-lasting adaptive immune memory specific to SARS-CoV-2 in convalescent coronavirus disease 2019 stable people with HIV.
Donadeu, Laura; Tiraboschi, Juan Manuel; Scévola, Sofía; Torija, Alba; Meneghini, Maria; Jouve, Thomas; Favà, Alexandre; Calatayud, Laura; Ardanuy, Carmen; Cidraque, Ignacio; Preyer, Rosemarie; Strecker, Kevin; Lozano, Juan J; Podzamczer, Daniel; Crespo, Elena; Bestard, Oriol.
Afiliação
  • Donadeu L; Laboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona.
  • Tiraboschi JM; HIV Unit, Infectious Disease Department, Bellvitge University Hospital.
  • Scévola S; HIV Unit, Infectious Disease Department, Bellvitge University Hospital.
  • Torija A; Laboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona.
  • Meneghini M; Laboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona.
  • Jouve T; Kidney Transplant Unit, Nephrology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona.
  • Favà A; Laboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona.
  • Calatayud L; Kidney Transplant Unit, Nephrology Department, Bellvitge University Hospital.
  • Ardanuy C; Microbiology Department, Bellvitge University Hospital, Barcelona, Spain.
  • Cidraque I; Microbiology Department, Bellvitge University Hospital, Barcelona, Spain.
  • Preyer R; Kidney Transplant Unit, Nephrology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona.
  • Strecker K; GenID GmbH, Strassberg, Germany.
  • Lozano JJ; GenID GmbH, Strassberg, Germany.
  • Podzamczer D; Bioinformatics Platform, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Catalonia, Spain.
  • Crespo E; HIV Unit, Infectious Disease Department, Bellvitge University Hospital.
  • Bestard O; Laboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona.
AIDS ; 36(10): 1373-1382, 2022 08 01.
Article em En | MEDLINE | ID: mdl-35730384
OBJECTIVE: While the course of natural immunization specific to SARS-CoV-2 has been described among convalescent coronavirus disease 2019 (COVID-19) people without HIV (PWOH), a thorough evaluation of long-term serological and functional T- and B-cell immune memory among people with HIV (PWH) has not been reported. METHODS: Eleven stable PWH developing mild ( n  = 5) and severe ( n  = 6) COVID-19 and 39 matched PWOH individuals with mild (MILD) ( n  = 20) and severe (SEV) ( n  = 19) COVID-19 infection were assessed and compared at 3 and 6 months after infection for SARS-CoV-2-specific serology, polyfunctional cytokine (interferon-γ [IFN-γ], interleukin 2 [IL-2], IFN-γ/IL-2, IL-21) producing T-cell frequencies against four main immunogenic antigens and for circulating SARS-CoV-2-specific immunoglobulin G (IgG)-producing memory B-cell (mBc). RESULTS: In all time points, all SARS-COV-2-specific adaptive immune responses were highly driven by the clinical severity of COVID-19 infection, irrespective of HIV disease. Notably, while a higher proportion of mild PWH showed a higher decay on serological detection between the two time points as compared to PWOH, persistently detectable IgG-producing mBc were still detectable in most patients (4/4 (100%) for SEV PWH, 4/5 (80%) for MILD PWH, 10/13 (76.92%) for SEV PWOH and 15/18 (83.33%) for MILD PWOH). Likewise, SARS-CoV-2-specific IFN-γ-producing T-cell frequencies were detected in both PWH and PWOH, although significantly more pronounced among severe COVID-19 (6/6 (100%) for SEV PWH, 3/5 (60%) for MILD PWH, 18/19 (94.74%) for SEV PWOH and 14/19 (73.68%) for MILD PWOH). CONCLUSIONS: PWH develop a comparable short and long-term natural functional cellular and humoral immune response than PWOH convalescent patients, which are highly influenced by the clinical severity of the COVID-19 infection.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Imunidade Adaptativa / COVID-19 / Memória Imunológica Limite: Humans Idioma: En Revista: AIDS Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Imunidade Adaptativa / COVID-19 / Memória Imunológica Limite: Humans Idioma: En Revista: AIDS Ano de publicação: 2022 Tipo de documento: Article